Levothyroxine detailed information

Levothyroxine detailed information

Clinical data
Pregnancy category	A (FDA)
Routes of administration	Oral, Intravenous
ATC code	H03AA01 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	~100%
Metabolism	Mainly in liver, kidneys, brain and muscles
Elimination half-life	ca. 7 days (in hyperthyroidism 3-4 days, in hypothyroidism 9-10 days)
Excretion	Through feces and urine
Identifiers
IUPAC name 3,5,3',5'-Tetraiodo-L-thyronine
CAS Number	51-48-9
PubChem CID	853
DrugBank	APRD00235
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C15H10I4NNaO4
Molar mass	798.86 (anhydrous)

WikiDoc Resources for Levothyroxine detailed information
Articles
Most recent articles on Levothyroxine detailed information Most cited articles on Levothyroxine detailed information Review articles on Levothyroxine detailed information Articles on Levothyroxine detailed information in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Levothyroxine detailed information Images of Levothyroxine detailed information Photos of Levothyroxine detailed information Podcasts & MP3s on Levothyroxine detailed information Videos on Levothyroxine detailed information
Evidence Based Medicine
Cochrane Collaboration on Levothyroxine detailed information Bandolier on Levothyroxine detailed information TRIP on Levothyroxine detailed information
Clinical Trials
Ongoing Trials on Levothyroxine detailed information at Clinical Trials.gov Trial results on Levothyroxine detailed information Clinical Trials on Levothyroxine detailed information at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Levothyroxine detailed information NICE Guidance on Levothyroxine detailed information NHS PRODIGY Guidance FDA on Levothyroxine detailed information CDC on Levothyroxine detailed information
Books
Books on Levothyroxine detailed information
News
Levothyroxine detailed information in the news Be alerted to news on Levothyroxine detailed information News trends on Levothyroxine detailed information
Commentary
Blogs on Levothyroxine detailed information
Definitions
Definitions of Levothyroxine detailed information
Patient Resources / Community
Patient resources on Levothyroxine detailed information Discussion groups on Levothyroxine detailed information Patient Handouts on Levothyroxine detailed information Directions to Hospitals Treating Levothyroxine detailed information Risk calculators and risk factors for Levothyroxine detailed information
Healthcare Provider Resources
Symptoms of Levothyroxine detailed information Causes & Risk Factors for Levothyroxine detailed information Diagnostic studies for Levothyroxine detailed information Treatment of Levothyroxine detailed information
Continuing Medical Education (CME)
CME Programs on Levothyroxine detailed information
International
Levothyroxine detailed information en Espanol Levothyroxine detailed information en Francais
Business
Levothyroxine detailed information in the Marketplace Patents on Levothyroxine detailed information
Experimental / Informatics
List of terms related to Levothyroxine detailed information

Levothyroxine, also known as L-thyroxine, synthetic T₄ or 3,5,3',5'-tetraiodo-L-thyronine, is a synthetic form of thyroxine (thyroid hormone). The natural hormone is chemically in the L-form, as is the pharmaceutical agent. Dextrothyroxine (D-thyroxine) briefly saw research as an anticholesterol agent but was pulled due to cardiac side-effects.

The EU has recently standardized the use of the name "levothyroxine" for the drug. Common brand names include ""Thyrax"", "Euthyrox", "Levaxin" and "Eltroxin" in Europe, and "Levoxyl" and "Synthroid" in the U.S. There are also numerous generic versions approved by the Food and Drug Administration.

Uses

This medicine is a hormone replacement usually given to patients with thyroid problems, specifically, hypothyroidism. It is also given to people who have Goitre or an enlarged thyroid gland.

Administration

It is recommended that levothyroxine be taken half an hour to an hour before meals to maximize its absorption. It is also recommended that the patient take the tablet with one glass of water to ease swallowing as well as to help the tablet dissolve for absorption.

Precautions and side effects

There are also foods and other substances that can interfere with absorption of thyroxine replacement. Avoid taking calcium and iron supplements within 4 hours of the medication and avoid taking soy products within 3 hours of the medication as these can reduce absorption of the medication.

Synthetic levothyroxine may have adverse side effects like: palpitations, nervousness, headache, difficulty sleeping, insomnia, swelling of the legs and ankles, weight loss and/or increased appetite. Some may be allergic to the medicine. If the patient develops a severe reaction to this drug like difficulty breathing, shortness of breath or swelling of the face and tongue it is imperative that the patient immediately seek medical attention.

Marketing and approvals

Levothyroxine 25mcg tablets

Synthroid is the most prescribed brand of T4 in United States. Synthroid was marketed in 1955, but was not FDA approved at that time as it was considered "generally regarded safe". In the 1990s, in response to debate as to whether Synthroid was more effective than other levothyroxine preparations, (which ended up concluding that there was little difference between Synthroid and generic brands all levothyroxine preparations were required to undergo the formal FDA approval process. Synthroid was approved by the FDA on 2002-07-24.

External links

• Detailed Euthyrox (Levothroid/Levothyroxine) Consumer Information: Uses, Precautions, Side Effects
• Leaflet

Template:WikiDoc Sources